top of page
.png)
Rapid CAR-T Platforms: AÂ Top-level Analysis
CAR-T therapy has dramatically changed the course of cancer management over the past few years. However, despite this impact, one of the...
Oncofocus Team
Apr 10, 20241 min read
Â
Targeting the PD-1/PD-L1 immunosuppressive axis: ​CAR-T strategies under investigation
PD-(L)1 axis inhibits CAR-T cell activation, proliferation, survival, and functionality. Thus, CAR-T mediated direct targeting of the...
Oncofocus Team
Jan 11, 20241 min read
Â
bottom of page